Thiogenesis Therapeutics, Inc.
3 clinical trials · Sponsor
◉ Watch Thiogenesis Therapeutics, Inc.
| Record | Firm | Date |
|---|---|---|
| A Dose-ranging Study of TTI-0102 in Adults and Children With Leigh Syndrome Spectrum (LSS) (NCT06990984) | Thiogenesis Therapeutics, Inc. | 2026-10-01 |
| A Study to Assess TTI-0102 vs Placebo in MELAS Patients (NCT06644534) | Thiogenesis Therapeutics, Inc. | 2025-05-12 |
| Study of Cysteamine-pantetheine Disulfide (TTI-0102) in Mild to Moderate COVID-19 (NCT05212662) | Thiogenesis Therapeutics, Inc. | 2024-09-27 |
Track Thiogenesis Therapeutics, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.